Km. Wasan et G. Lopezberestein, CHARACTERISTICS OF LIPID-BASED FORMULATIONS THAT INFLUENCE THEIR BIOLOGICAL BEHAVIOR IN THE PLASMA OF PATIENTS, Clinical infectious diseases, 23(5), 1996, pp. 1126-1138
Patients with cancer and infectious diseases often have changes in the
composition and concentration of their different blood components, Th
ese changes include variations in the composition and concentration of
plasma lipoprotein lipids, in transfer rates of endogenous lipid betw
een different lipoprotein classes, and in concentrations of phagocytic
cells (i.e., monocytes and macrophages). It appears that the interact
ion of many lipid-based drug formulations with plasma lipoproteins and
blood phagocytic cells may be responsible for the unpredictable pharm
acokinetics and pharmacodynamics of these compounds when administered
to patients with diseases. This review examines the potential mechanis
ms that may explain the biological behavior of lipid-based drug formul
ations used in the treatment of infectious diseases and cancer.